---
category: news
title: "FDA Breakthrough Device Designation Is Granted to Avenda Health for Laser Ablation System in Prostate Cancer"
excerpt: "the company responsible for developing the artificial intelligence (AI)–enabled focal therapy system. 1 The product intended for use as a male “lumpectomy” device was developed as an alternative to traditional surgery or radiation, for which the ..."
publishedDateTime: 2021-05-12T16:01:00Z
originalUrl: "https://www.cancernetwork.com/view/fda-breakthrough-device-designation-is-granted-to-avenda-health-for-laser-ablation-system-in-prostate-cancer"
webUrl: "https://www.cancernetwork.com/view/fda-breakthrough-device-designation-is-granted-to-avenda-health-for-laser-ablation-system-in-prostate-cancer"
type: article
quality: 5
heat: -1
published: false

provider:
  name: Cancer Network
  domain: cancernetwork.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://cdn.sanity.io/images/0vv8moc6/cancernetwork/8f45ea8da433fb93e9731b0c2c57b2c4d6e48535-3353x3353.jpg?auto=format"
    width: 3353
    height: 3353
    isCached: true

related:
  - title: "AI-Enabled Prostate Cancer Therapy Wins Breakthrough Designation"
    excerpt: "Avenda Health said its focal therapy system uses artificial intelligence to treat localized prostate cancer in a urologist’s office under local anesthesia."
    publishedDateTime: 2021-05-11T17:01:00Z
    webUrl: "https://www.mddionline.com/artificial-intelligence/ai-enabled-prostate-cancer-therapy-wins-breakthrough-designation"
    type: article
    provider:
      name: MD&M East
      domain: mddionline.com
    quality: 54
    images:
      - url: "https://www.mddionline.com/sites/mddionline.com/files/IMG_May112021at124830PM.png"
        width: 770
        height: 400
        isCached: true
  - title: "FDA grants breakthrough device designation to AI-based focal therapy system"
    excerpt: "The targeted focal laser ablation system is intended to be an office-based treatment for localized prostate cancer delivered under local anesthesia."
    publishedDateTime: 2021-05-11T00:00:00Z
    webUrl: "https://www.urologytimes.com/view/fda-grants-breakthrough-device-designation-to-ai-based-focal-therapy-system"
    type: article
    provider:
      name: urologytimes
      domain: urologytimes.com
    quality: 52
    images:
      - url: "https://cdn.sanity.io/images/0vv8moc6/urologytimes/33bac5b4b295369649455c6e7f13d51c0b268650-500x218.jpg?auto=format"
        width: 500
        height: 218
        isCached: true
  - title: "Avenda Health Granted FDA Breakthrough Device Designation for Technology to Treat Prostate Cancer"
    excerpt: "Breakthrough Device Designation was awarded to Avenda Health for a male “lumpectomy” product in development designed to treat prostate cancer in-office while preserving quality of life. Breakthrough Device Designation by FDA is reserved for devices that are potentially transformative,"
    publishedDateTime: 2021-05-11T16:00:00Z
    webUrl: "https://www.businesswire.com/news/home/20210511005137/en/Avenda-Health-Granted-FDA-Breakthrough-Device-Designation-for-Technology-to-Treat-Prostate-Cancer"
    type: article
    provider:
      name: Business Wire
      domain: businesswire.com
    quality: 0
  - title: "FDA Grants Breakthrough Device Designation to Lumpectomy Product in Prostate Cancer"
    excerpt: "The FDA has granted a breakthrough device designation to the Avenda Health Focal Therapy System, a male “lumpectomy” product under development to treat patients with prostate cancer in office while preserving quality of life."
    publishedDateTime: 2021-05-11T20:10:00Z
    webUrl: "https://www.onclive.com/view/fda-grants-breakthrough-device-designation-to-lumpectomy-product-in-prostate-cancer"
    type: article
    provider:
      name: OncLive.com
      domain: onclive.com
    quality: 0

secured: "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;8i8C7D9tPoFLFdWnrSmujg=="
---

